Literature DB >> 26261500

LncRNA-AP001631.9 promotes cell migration in gastric cancer.

Hui Cai1, Xiaojuan Ye1, Bin He2, Qiang Li1, Yandong Li1, Yong Gao1.   

Abstract

Recently, an increasing number of reports have revealed that long non-coding RNAs (LncRNAs) play important roles in a variety of aspects of cell activity, and their aberrant expression is closely associated with multigenetic diseases, including carcinoma. In the present study, through microarray analysis, we screened out a new LncRNA (LncRNA-AP001631.9), which was regulated by FOXM1, a well-known carcinogenetic factor and aimed to reveal the functional roles of this novel LncRNA in gastric cancer development. The data from qRT-PCR confirmed that the expression level of LncRNA-AP001631.9 was positively correlated with that of FOXM1. The transwell and wound healing assays indicated that LncRNA-AP001631.9 was required for the migration of gastric cancer cells. The downregulation of LncRNA-AP001631.9 by small interference RNA suppressed the migratory ability of MGC803 and AGS cells, while the overexpression of LncRNA-AP001631.9 promoted the movement of BGC823 and SGC7901 cells. Furthermore, a tail vein injection was administered, and the obtained results suggested that LncRNA-AP001631.9 contributed to the distant metastasis of SGC7901 cells. Moreover, we also collected 36 paired samples of gastric cancer tissues to explore the expression levels of LncRNA-AP001631.9. The qRT-PCR data indicated that the LncRNA-AP001631.9 expression was frequently increased in gastric cancer tissues. Taken together, our findings established that LncRNA-AP001631.9 plays critical roles in gastric cancer progression and can serve as a potential new target for the treatment of gastric cancer.

Entities:  

Keywords:  FoxM1; LncRNA; cell migration; gastric cancer

Mesh:

Substances:

Year:  2015        PMID: 26261500      PMCID: PMC4525834     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

Review 1.  Genome regulation by long noncoding RNAs.

Authors:  John L Rinn; Howard Y Chang
Journal:  Annu Rev Biochem       Date:  2012       Impact factor: 23.643

Review 2.  Non-coding RNAs in human disease.

Authors:  Manel Esteller
Journal:  Nat Rev Genet       Date:  2011-11-18       Impact factor: 53.242

Review 3.  Long non-coding RNAs: challenges for diagnosis and therapies.

Authors:  Yolanda Sánchez; Maite Huarte
Journal:  Nucleic Acid Ther       Date:  2013-02       Impact factor: 5.486

Review 4.  Forkhead box proteins: tuning forks for transcriptional harmony.

Authors:  Eric W-F Lam; Jan J Brosens; Ana R Gomes; Chuay-Yeng Koo
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

Review 5.  Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?

Authors:  Cecília Durães; Gabriela M Almeida; Raquel Seruca; Carla Oliveira; Fátima Carneiro
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

Review 6.  An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.

Authors:  Hiroyuki Yamamoto; Yoshiyuki Watanabe; Tadateru Maehata; Ryo Morita; Yoshihito Yoshida; Ritsuko Oikawa; Shinya Ishigooka; Shun-Ichiro Ozawa; Yasumasa Matsuo; Kosuke Hosoya; Masaki Yamashita; Hiroaki Taniguchi; Katsuhiko Nosho; Hiromu Suzuki; Hiroshi Yasuda; Yasuhisa Shinomura; Fumio Itoh
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

7.  FOXM1 is a downstream target of Gli1 in basal cell carcinomas.

Authors:  Muy-Teck Teh; Soon-Tee Wong; Graham W Neill; Lucy R Ghali; Michael P Philpott; Anthony G Quinn
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

Review 8.  The functional role of long non-coding RNA in human carcinomas.

Authors:  Ewan A Gibb; Carolyn J Brown; Wan L Lam
Journal:  Mol Cancer       Date:  2011-04-13       Impact factor: 27.401

9.  Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer.

Authors:  Ana C Tahira; Márcia S Kubrusly; Michele F Faria; Bianca Dazzani; Rogério S Fonseca; Vinicius Maracaja-Coutinho; Sergio Verjovski-Almeida; Marcel C C Machado; Eduardo M Reis
Journal:  Mol Cancer       Date:  2011-11-13       Impact factor: 27.401

10.  Low expression of LOC285194 is associated with poor prognosis in colorectal cancer.

Authors:  Peng Qi; Mi-die Xu; Shu-juan Ni; Dan Huang; Ping Wei; Cong Tan; Xiao-yan Zhou; Xiang Du
Journal:  J Transl Med       Date:  2013-05-16       Impact factor: 5.531

View more
  5 in total

1.  Differentially Expressed Long Non-Coding RNAs Were Predicted to Be Involved in the Control of Signaling Pathways in Pediatric Astrocytoma.

Authors:  Ruth Ruiz Esparza-Garrido; Juan Manuel Rodríguez-Corona; Javier Enrique López-Aguilar; Marco Antonio Rodríguez-Florido; Ana Claudia Velázquez-Wong; Rubí Viedma-Rodríguez; Fabio Salamanca-Gómez; Miguel Ángel Velázquez-Flores
Journal:  Mol Neurobiol       Date:  2016-10-13       Impact factor: 5.590

2.  miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation.

Authors:  Tongbao Feng; Fang Shao; Qiyong Wu; Xiaohang Zhang; Dongqin Xu; Keqing Qian; Yewen Xie; Shizhong Wang; Ning Xu; Yong Wang; Chunjian Qi
Journal:  Oncotarget       Date:  2016-03-29

3.  Improved method for prioritization of disease associated lncRNAs based on ceRNA theory and functional genomics data.

Authors:  Peng Wang; Qiuyan Guo; Yue Gao; Hui Zhi; Yan Zhang; Yue Liu; Jizhou Zhang; Ming Yue; Maoni Guo; Shangwei Ning; Guangmei Zhang; Xia Li
Journal:  Oncotarget       Date:  2017-01-17

Review 4.  Long noncoding RNAs and their link to cancer.

Authors:  Justine M Grixti; Duncan Ayers
Journal:  Noncoding RNA Res       Date:  2020-05-13

Review 5.  One stomach, two subtypes of carcinoma-the differences between distal and proximal gastric cancer.

Authors:  Yuan Zhang; Peng-Shan Zhang; Ze-Yin Rong; Chen Huang
Journal:  Gastroenterol Rep (Oxf)       Date:  2021-11-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.